Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
CJC-1295 extends and amplifies it
Alternative options include SGLT2 inhibitors (which offer cardiovascular and renal benefits), switching from a DPP-4 inhibitor to a GLP-1 receptor agonist, adding insulin therapy, or considering other medication classes based on your individual circumstances
Coverage is likely to keep changing as new clinical evidence emerges, obesity is increasingly treated as a chronic disease, employers assess long-term health costs, and patient demand grows
When hormone-sensitive lipase is active, it cleaves the bonds holding triglycerides together, releasing fatty acids into the bloodstream where they can be oxidized for energy
US$ 20.22
US$ 20.40
US$ 20.87
US$ 23.24
US$ 28.04
US$ 25.85
US$ 24.14
